We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

41 hedge funds and large institutions have $1.09M invested in Oncolytics Biotech in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.96% less ownership

Funds ownership: 2.2% → 1.23% (-0.96%)

9% less funds holding

Funds holding: 45 → 41 (-4)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

36% less capital invested

Capital invested by funds: $1.69M → $1.09M (-$602K)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
+$16.8K
2
CIBC World Market
CIBC World Market
Ontario, Canada
+$14K
3
IAIM
International Assets Investment Management
Florida
+$11.4K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$8.74K
5
Osaic Holdings
Osaic Holdings
Arizona
+$8.48K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$352K
2
Citadel Advisors
Citadel Advisors
Florida
-$140K
3
ARC
Advisor Resource Council
Texas
-$139K
4
JP Morgan Chase
JP Morgan Chase
New York
-$50K
5
Morgan Stanley
Morgan Stanley
New York
-$47.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Strategic Asset Management
Minnesota
$4K +$4.19K +2,500 New
ACM
27
Aquatic Capital Management
Illinois
$2K -$2.18K -1,300 -50%
TRCT
28
Tower Research Capital (TRC)
New York
$2K -$1.29K -767 -45%
SN
29
Sittner & Nelson
Oregon
$2K – – –
MCC
30
Money Concepts Capital
Florida
$2K +$1.78K +1,060 New
IA
31
IFP Advisors
Florida
$1K +$201 +120 New
QC
32
Quent Capital
New York
$1K +$795 +474 New
HNWAG
33
High Net Worth Advisory Group
Florida
$1K +$839 +500 New
TWC
34
TD Waterhouse Canada
Ontario, Canada
$796 -$1.83K -1,089 -73%
NDSI
35
Newman Dignan & Sheerar Inc
Rhode Island
$20 -$1.68K -1,000 -7%
ARC
36
Advisor Resource Council
Texas
– -$139K -100,000 Closed
JP Morgan Chase
37
JP Morgan Chase
New York
– -$50K -36,235 Closed
TSS
38
Two Sigma Securities
New York
– -$38K -27,125 Closed
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
– -$14K -10,059 Closed
Toronto Dominion Bank
40
Toronto Dominion Bank
Ontario, Canada
– -$7K -5,154 Closed
TCOV
41
Trust Company of Vermont
Vermont
– -$7K -5,000 Closed
UBS Group
42
UBS Group
Switzerland
– -$5.27K -3,140 -95%
1
2

ONCY Hedge Fund Activity: Q1 2022 in Review

41 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q1 2022, worth a combined $1.09M — down 36% from $1.69M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ONCY and 5 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 8 added.

The largest buyer was Fifth Third Bancorp, adding an estimated $16.8K. The largest seller was Renaissance Technologies, cutting an estimated $352K.

  • 41 institutional investors held Oncolytics Biotech (ONCY) as of Q1 2022, down from 45 in Q4 2021.
  • Funds reported $1.09M of Oncolytics Biotech stock for Q1 2022, down 36% quarter-over-quarter.
  • 5 funds opened new Oncolytics Biotech positions in Q1 2022 and 8 closed out, a net change of -3 holders.
  • The largest Oncolytics Biotech buyer in Q1 2022 was Fifth Third Bancorp, an estimated $16.8K added.
  • The largest Oncolytics Biotech seller in Q1 2022 was Renaissance Technologies, an estimated $352K sold.

Based on aggregated 13F filings for Q1 2022.